• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病神经病理学谜题:一项系统性综述揭示这种神经疾病背后的病理元凶

Parkinson's Neuropathology Puzzle: A Systematic Review Uncovering the Pathological Culprits Behind the Neurological Disease.

作者信息

Abaza Abdelrahman, Jamil Aneeque, Gutlapalli Sai Dheeraj, Ali Marya, Oble Mrinal J P, Sonia Shamsun Nahar, George Sherie, Shahi Srushti R, Ali Zahra, Khan Safeera

机构信息

Pathology, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.

Internal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.

出版信息

Cureus. 2023 Aug 29;15(8):e44353. doi: 10.7759/cureus.44353. eCollection 2023 Aug.

DOI:10.7759/cureus.44353
PMID:37664277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10472082/
Abstract

Being one of the most prevalent progressive neurodegenerative disorders (falling second only to Alzheimer's disease) with a clinical pattern affecting millions of lives all over the world, Parkinson's disease (PD) has never failed to attract a formidable interest from the vast majority of neurologists and researchers worldwide. This review article will analyze the pathophysiology, etiology, genetics, and pathological stages of Parkinson's disease with their corresponding clinical sequels. A review article was conducted using research databases including PubMed, PubMed Central, Springer, and Elsevier. The research articles reviewed using databases were written in English, German, Japanese, and Chinese and published within the preceding 50 years. Based on the article's findings, we concluded that Parkinson's disease is a progressive disorder with a variety of motor and non-motor symptoms that are influenced by a cascade of pathological neuronal abnormalities such as Lewy neurites and Lewy bodies that gradually build up with an eventual consequence of neurodegeneration of dopamine-secreting neurons. Multiple genetic mutations, pathophysiological events, and environmental factors act as the foundation to initiate that cascade.

摘要

帕金森病(PD)是最常见的进行性神经退行性疾病之一(仅次于阿尔茨海默病),其临床症状影响着全球数百万人的生活,一直以来都吸引着全球绝大多数神经科医生和研究人员的极大关注。这篇综述文章将分析帕金森病的病理生理学、病因学、遗传学和病理阶段及其相应的临床后果。我们使用包括PubMed、PubMed Central、Springer和Elsevier在内的研究数据库进行了综述。使用这些数据库检索的研究文章以英文、德文、日文和中文撰写,并发表于过去50年内。基于文章的研究结果,我们得出结论:帕金森病是一种进行性疾病,具有多种运动和非运动症状,这些症状受到一系列病理性神经元异常(如路易神经突和路易小体)的影响,这些异常逐渐累积,最终导致多巴胺分泌神经元发生神经退行性变。多种基因突变、病理生理事件和环境因素是引发这一系列变化的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/e5afa6b1fba0/cureus-0015-00000044353-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/dcf2a2fb7d9c/cureus-0015-00000044353-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/36353db66f9c/cureus-0015-00000044353-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/5c6262c895ac/cureus-0015-00000044353-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/c4385033cf3f/cureus-0015-00000044353-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/12108b2201d0/cureus-0015-00000044353-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/bc7f0c12843a/cureus-0015-00000044353-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/e5afa6b1fba0/cureus-0015-00000044353-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/dcf2a2fb7d9c/cureus-0015-00000044353-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/36353db66f9c/cureus-0015-00000044353-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/5c6262c895ac/cureus-0015-00000044353-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/c4385033cf3f/cureus-0015-00000044353-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/12108b2201d0/cureus-0015-00000044353-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/bc7f0c12843a/cureus-0015-00000044353-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab44/10472082/e5afa6b1fba0/cureus-0015-00000044353-i07.jpg

相似文献

1
Parkinson's Neuropathology Puzzle: A Systematic Review Uncovering the Pathological Culprits Behind the Neurological Disease.帕金森病神经病理学谜题:一项系统性综述揭示这种神经疾病背后的病理元凶
Cureus. 2023 Aug 29;15(8):e44353. doi: 10.7759/cureus.44353. eCollection 2023 Aug.
2
The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.多巴胺能系统神经退行性变症状患者的多巴胺能成像作用。
Brain. 2011 Nov;134(Pt 11):3146-66. doi: 10.1093/brain/awr177. Epub 2011 Aug 2.
3
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].帕金森病的病因与发病机制:从线粒体功能障碍到家族性帕金森病
Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62.
4
The second brain and Parkinson's disease.第二大脑与帕金森病。
Eur J Neurosci. 2009 Sep;30(5):735-41. doi: 10.1111/j.1460-9568.2009.06873.x. Epub 2009 Aug 27.
5
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
6
Parkinson's disease: Autoimmunity and neuroinflammation.帕金森病:自身免疫与神经炎症。
Autoimmun Rev. 2016 Oct;15(10):1005-11. doi: 10.1016/j.autrev.2016.07.022. Epub 2016 Aug 4.
7
How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?重组腺相关病毒-α-突触核蛋白和丝状α-突触核蛋白模型如何促进我们对帕金森病的理解?
J Neurochem. 2016 Oct;139 Suppl 1(Suppl 1):131-155. doi: 10.1111/jnc.13627. Epub 2016 May 4.
8
Altered awareness of cognitive and neuropsychiatric symptoms in Parkinson's disease and Dementia with Lewy Bodies: A systematic review.帕金森病和路易体痴呆认知和神经精神症状意识改变:系统评价。
Int J Geriatr Psychiatry. 2021 Jan;36(1):15-30. doi: 10.1002/gps.5415. Epub 2020 Sep 14.
9
Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.柚皮素:一种用于治疗阿尔茨海默病和帕金森病的潜在治疗药物。
J Food Biochem. 2022 Dec;46(12):e14415. doi: 10.1111/jfbc.14415. Epub 2022 Sep 15.
10
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.路易体痴呆与帕金森病痴呆:当前的概念和争议。
J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8.

本文引用的文献

1
Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite.帕金森病蛋白 PARK7 可防止糖酵解代谢物引起的代谢物和蛋白质损伤。
Proc Natl Acad Sci U S A. 2022 Jan 25;119(4). doi: 10.1073/pnas.2111338119.
2
Neuropathology and molecular diagnosis of Synucleinopathies.神经病理学和神经核蛋白病的分子诊断。
Mol Neurodegener. 2021 Dec 18;16(1):83. doi: 10.1186/s13024-021-00501-z.
3
Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease.α-突触核蛋白在帕金森病炎症性突触病中的突出作用。
Int J Mol Sci. 2021 Jun 17;22(12):6517. doi: 10.3390/ijms22126517.
4
Non-Genetic Risk Factors for Parkinson's Disease: An Overview of 46 Systematic Reviews.帕金森病的非遗传风险因素:46 项系统评价综述。
J Parkinsons Dis. 2021;11(3):919-935. doi: 10.3233/JPD-202521.
5
The Pathology of Parkinson's Disease and Potential Benefit of Dietary Polyphenols.帕金森病的病理学与膳食多酚的潜在益处。
Molecules. 2020 Sep 24;25(19):4382. doi: 10.3390/molecules25194382.
6
Novel approaches to counter protein aggregation pathology in Parkinson's disease.新型方法对抗帕金森病中的蛋白质聚集病变。
Prog Brain Res. 2020;252:451-492. doi: 10.1016/bs.pbr.2019.10.007. Epub 2019 Nov 30.
7
Parkinson's disease treatment: past, present, and future.帕金森病的治疗:过去、现在和未来。
J Neural Transm (Vienna). 2020 May;127(5):785-791. doi: 10.1007/s00702-020-02167-1. Epub 2020 Mar 14.
8
Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.帕金森病的流行病学、病理学、遗传学和发病机制。
Clin Geriatr Med. 2020 Feb;36(1):1-12. doi: 10.1016/j.cger.2019.08.002. Epub 2019 Aug 24.
9
Glucocerebrosidase and its relevance to Parkinson disease.葡萄糖脑苷脂酶及其与帕金森病的关系。
Mol Neurodegener. 2019 Aug 29;14(1):36. doi: 10.1186/s13024-019-0336-2.
10
SANRA-a scale for the quality assessment of narrative review articles.SANRA——一种用于叙述性综述文章质量评估的量表。
Res Integr Peer Rev. 2019 Mar 26;4:5. doi: 10.1186/s41073-019-0064-8. eCollection 2019.